Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $10.17 trillion, total revenue of $4.72 trillion and a weighted average PE ratio of 48.07.
Market Cap
10.17T
Revenue
4.72T
Profits
211.54B
PE Ratio
48.07
Profit Margin
4.48%
Dividend Yield
0.37%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | 0.61% | 3,640,772 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 665.19B | 3.81% | 9,622,177 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 521.15B | 3.09% | 8,435,134 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 370.96B | 3.93% | 10,719,782 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 366.81B | 1.22% | 9,529,081 | 450.06B |
| 6 | NVS | Novartis AG | 310.29B | 3.59% | 1,744,891 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 292.89B | 2.79% | 4,556,299 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 261.64B | 1.12% | 2,460,841 | 47.35B |
| 9 | AMGN | Amgen Inc. | 258.68B | 3.73% | 4,620,139 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 216.41B | 4.19% | 9,636,516 | 30.99B |
| 11 | ABT | Abbott Laboratories | 199.88B | 5.59% | 12,712,206 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 188.84B | 4.95% | 26,038,263 | 50.70B |
| 13 | PFE | Pfizer Inc. | 175.50B | 2.63% | 49,921,028 | 63.63B |
| 14 | ISRG | Intuitive Surgical, Inc. | 167.12B | 9.38% | 4,826,219 | 11.58B |
| 15 | DHR | Danaher Corporation | 165.28B | 2.09% | 3,055,474 | 25.61B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 139.20B | 3.44% | 1,832,584 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 131.21B | 4.02% | 14,127,342 | 50.03B |
| 18 | SYK | Stryker Corporation | 129.30B | 9.37% | 6,488,334 | 26.30B |
| 19 | MDT | Medtronic plc | 128.49B | 6.15% | 11,572,399 | 37.54B |
| 20 | MCK | McKesson Corporation | 124.69B | 6.98% | 1,172,044 | 418.79B |
| 21 | SNY | Sanofi | 113.07B | 4.72% | 5,485,085 | 57.89B |
| 22 | HCA | HCA Healthcare, Inc. | 106.68B | 10.34% | 3,446,655 | 78.70B |
| 23 | MRNA | Moderna, Inc. | 103.15B | 13.11% | 14,808,314 | 2.23B |
| 24 | CVS | CVS Health Corporation | 102.27B | -12.53% | 34,289,772 | 418.38B |
| 25 | GSK | GSK plc | 102.03B | 5.03% | 5,281,283 | 44.53B |
| 26 | ELV | Elevance Health, Inc. | 93.81B | 4.94% | 1,729,293 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 93.39B | -4.39% | 1,395,271 | 16.90B |
| 28 | CI | The Cigna Group | 80.70B | 3.37% | 2,431,101 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.44B | 1.49% | 2,975,730 | 29.86B |
| 30 | COR | Cencora, Inc. | 67.55B | 3.96% | 2,887,541 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 66.41B | 5.33% | 34,559,158 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 60.65B | 3.55% | 2,457,642 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 57.28B | 4.39% | 7,897,497 | 6.67B |
| 34 | ARGX | argenx SE | 57.20B | 3.36% | 645,892 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 56.98B | 5.56% | 4,460,588 | 22.48B |
| 36 | NTRA | Natera, Inc. | 56.36B | 0.62% | 2,800,573 | 2.71B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 55.04B | 3.94% | 1,398,902 | 4.66B |
| 38 | MDLN | Medline Inc. | 53.05B | 18.36% | 25,468,438 | 30.68B |
| 39 | VEEV | Veeva Systems Inc. | 50.29B | 2.45% | 1,443,130 | 3.46B |
| 40 | HUM | Humana Inc. | 50.12B | -0.11% | 1,859,440 | 145.68B |
| 41 | A | Agilent Technologies, Inc. | 49.95B | 0.97% | 1,642,030 | 7.37B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 48.83B | -0.14% | 10,042,052 | 17.23B |
| 43 | WAT | Waters Corporation | 45.94B | 1.67% | 1,086,284 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 43.47B | 0.46% | 1,379,539 | 17.31B |
| 45 | ONC | BeOne Medicines AG | 42.95B | 6.42% | 630,179 | 6.61B |
| 46 | RVMD | Revolution Medicines, Inc. | 42.80B | 2.82% | 2,550,351 | 197.56M |
| 47 | HLN | Haleon plc | 40.04B | 4.41% | 28,018,445 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.85B | 1.75% | 3,795,945 | 2.62B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 38.80B | 6.38% | 9,605,105 | 21.64B |
| 50 | CNC | Centene Corporation | 37.63B | 12.64% | 15,151,796 | 180.41B |
| 51 | BIIB | Biogen Inc. | 37.61B | 2.22% | 1,348,003 | 10.30B |
| 52 | ALC | Alcon Inc. | 37.43B | 6.83% | 3,748,929 | 10.86B |
| 53 | ZTS | Zoetis Inc. | 36.86B | 7.48% | 9,177,330 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 34.53B | 1.48% | 211,762 | 4.13B |
| 55 | ILMN | Illumina, Inc. | 34.25B | -4.90% | 3,036,411 | 4.54B |
| 56 | RMD | ResMed Inc. | 33.83B | 5.91% | 2,258,256 | 5.73B |
| 57 | DXCM | DexCom, Inc. | 33.00B | 6.64% | 5,249,001 | 5.10B |
| 58 | GMAB | Genmab A/S | 32.11B | -0.72% | 4,299,451 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 30.04B | 9.14% | 3,023,858 | 20.16B |
| 60 | LH | Labcorp Holdings Inc. | 29.86B | 3.92% | 809,673 | 14.59B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.48B | 0.44% | 1,054,872 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.13B | 3.49% | 916,096 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 27.61B | 6.08% | 11,665,376 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 26.10B | 1.19% | 946,056 | 3.19B |
| 65 | INCY | Incyte Corporation | 25.04B | 4.47% | 2,140,862 | 6.01B |
| 66 | STE | STERIS plc | 24.17B | 7.16% | 1,380,525 | 6.17B |
| 67 | INSM | Insmed Incorporated | 24.13B | 5.32% | 4,944,544 | 1.52B |
| 68 | THC | Tenet Healthcare Corporation | 23.26B | 9.58% | 2,085,752 | 22.15B |
| 69 | GH | Guardant Health, Inc. | 22.62B | -3.67% | 2,267,640 | 1.18B |
| 70 | BNTX | BioNTech SE | 22.49B | 4.35% | 1,352,954 | 2.75B |
| 71 | VTRS | Viatris Inc. | 22.08B | 1.59% | 8,448,093 | 14.74B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.57B | 0.74% | 3,637,829 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 21.01B | 13.49% | 6,170,149 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.37B | -1.01% | 232,665 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.79B | -2.48% | 2,860,697 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.75B | 0.61% | 3,014,150 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.94B | 3.10% | 655,805 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.81B | 0.73% | 2,266,768 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.62B | -7.27% | 1,729,429 | 3.98B |
| 80 | ICLR | ICON Public Limited Company | 15.22B | -0.32% | 1,263,522 | 8.23B |
| 81 | SOLV | Solventum Corporation | 15.21B | 5.42% | 2,168,017 | 8.31B |
| 82 | BBIO | BridgeBio Pharma, Inc. | 15.17B | 5.21% | 5,552,354 | 945.54M |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 15.06B | 2.14% | 899,092 | 4.72B |
| 84 | HALO | Halozyme Therapeutics, Inc. | 14.79B | 1.34% | 1,613,008 | 1.66B |
| 85 | GKOS | Glaukos Corporation | 14.60B | 5.86% | 2,081,410 | 690.33M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 14.54B | -0.06% | 3,088,124 | 15.25B |
| 87 | EHC | Encompass Health Corporation | 13.84B | 4.63% | 1,016,376 | 6.34B |
| 88 | TEM | Tempus AI, Inc. | 13.79B | -2.81% | 5,936,354 | 1.51B |
| 89 | BAX | Baxter International Inc. | 13.71B | 3.96% | 10,491,637 | 11.61B |
| 90 | SNN | Smith & Nephew plc | 13.41B | 7.59% | 2,679,848 | 6.30B |
| 91 | SMMT | Summit Therapeutics Inc. | 12.93B | 2.34% | 4,258,105 | - |
| 92 | PEN | Penumbra, Inc. | 12.71B | 0.76% | 374,300 | 1.56B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.65B | 3.01% | 7,746,225 | 5.02B |
| 94 | COO | The Cooper Companies, Inc. | 12.25B | 5.90% | 3,265,848 | 4.24B |
| 95 | DVA | DaVita Inc. | 12.12B | 5.76% | 1,158,976 | 14.17B |
| 96 | RDY | Dr. Reddy's Laboratories Limited | 12.00B | 3.29% | 2,115,823 | 3.44B |
| 97 | FMS | Fresenius Medical Care AG | 11.92B | 6.72% | 2,310,299 | 22.12B |
| 98 | MOH | Molina Healthcare, Inc. | 11.79B | 8.93% | 2,243,008 | 42.08B |
| 99 | ALGN | Align Technology, Inc. | 11.71B | 8.79% | 1,697,414 | 4.16B |
| 100 | GMED | Globus Medical, Inc. | 11.69B | 9.45% | 2,351,238 | 3.14B |
| 101 | KYMR | Kymera Therapeutics, Inc. | 11.63B | 7.21% | 1,824,460 | 102.24M |
| 102 | UHS | Universal Health Services, Inc. | 11.58B | 10.91% | 1,782,050 | 18.35B |
| 103 | PODD | Insulet Corporation | 11.44B | 6.56% | 2,604,117 | 3.19B |
| 104 | TECH | Bio-Techne Corporation | 11.41B | 0.10% | 4,206,591 | 1.22B |
| 105 | RGEN | Repligen Corporation | 11.39B | -0.04% | 1,058,141 | 805.61M |
| 106 | BMRN | BioMarin Pharmaceutical Inc. | 11.06B | 2.64% | 3,223,295 | 3.66B |
| 107 | ENSG | The Ensign Group, Inc. | 10.89B | 3.35% | 527,215 | 5.67B |
| 108 | OSCR | Oscar Health, Inc. | 10.85B | 8.58% | 13,521,282 | 15.32B |
| 109 | AVTR | Avantor, Inc. | 10.60B | 0.38% | 10,046,619 | 6.64B |
| 110 | QGEN | Qiagen N.V. | 10.51B | 0.89% | 3,228,032 | 2.12B |
| 111 | PCVX | Vaxcyte, Inc. | 10.34B | 8.01% | 2,257,760 | - |
| 112 | BIO | Bio-Rad Laboratories, Inc. | 10.16B | 1.35% | 281,798 | 2.59B |
| 113 | HSIC | Henry Schein, Inc. | 9.75B | 6.96% | 3,904,639 | 13.73B |
| 114 | HNGE | Hinge Health, Inc. | 9.75B | 3.45% | 2,064,074 | 800.82M |
| 115 | BRKR | Bruker Corporation | 9.72B | 12.90% | 7,408,479 | 3.51B |
| 116 | IBRX | ImmunityBio, Inc. | 9.46B | 7.72% | 9,778,454 | 165.79M |
| 117 | SYRE | Spyre Therapeutics, Inc. | 9.41B | -0.23% | 1,495,489 | - |
| 118 | CAI | Caris Life Sciences, Inc. | 9.39B | 1.13% | 4,094,468 | 1.05B |
| 119 | ATR | AptarGroup, Inc. | 9.31B | 3.20% | 672,469 | 3.99B |
| 120 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.30B | 1.04% | 2,313,785 | 1.43B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.28B | 2.23% | 777,232 | 281.99M |
| 122 | KRYS | Krystal Biotech, Inc. | 9.21B | 1.90% | 414,444 | 470.03M |
| 123 | HQY | HealthEquity, Inc. | 9.00B | 6.67% | 1,573,575 | 1.36B |
| 124 | TWST | Twist Bioscience Corporation | 8.94B | 1.63% | 2,006,911 | 431.80M |
| 125 | CYTK | Cytokinetics, Incorporated | 8.84B | 2.07% | 2,917,188 | 113.29M |
| 126 | TXG | 10x Genomics, Inc. | 8.80B | 3.42% | 2,923,799 | 616.91M |
| 127 | TGTX | TG Therapeutics, Inc. | 8.74B | 1.45% | 2,039,833 | 799.54M |
| 128 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.71B | 3.56% | 1,615,708 | 669.50M |
| 129 | CORT | Corcept Therapeutics Incorporated | 8.67B | -3.31% | 2,195,657 | 963.65M |
| 130 | PACS | PACS Group, Inc. | 7.98B | 7.67% | 1,790,496 | 5.71B |
| 131 | PRAX | Praxis Precision Medicines, Inc. | 7.95B | 1.53% | 372,765 | 7.46M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.78B | 0.88% | 568,331 | 5.33M |
| 133 | ALKS | Alkermes plc | 7.70B | 0.44% | 2,179,091 | 1.75B |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.67B | 28.04% | 5,489,583 | 280.75M |
| 135 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.55B | 3.03% | 861,467 | 945.96M |
| 136 | GRFS | Grifols, S.A. | 7.50B | 0.58% | 674,600 | 8.63B |
| 137 | BLCO | Bausch + Lomb Corporation | 7.36B | 2.85% | 1,129,426 | 5.42B |
| 138 | AXSM | Axsome Therapeutics, Inc. | 7.21B | -1.87% | 1,034,196 | 865.27M |
| 139 | CHE | Chemed Corporation | 7.11B | 2.81% | 227,192 | 2.66B |
| 140 | AMRX | Amneal Pharmaceuticals, Inc. | 6.95B | -1.29% | 7,234,753 | 3.20B |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.71B | 1.87% | 790,252 | - |
| 142 | IONS | Ionis Pharmaceuticals, Inc. | 6.67B | -0.67% | 4,102,755 | 874.09M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.60B | 0.34% | 1,095,296 | 1.56B |
| 144 | GRAL | GRAIL, Inc. | 6.42B | 3.03% | 764,527 | 166.60M |
| 145 | TFX | Teleflex Incorporated | 6.35B | 7.09% | 1,293,003 | 2.25B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.33B | 11.42% | 1,153,705 | 670.78M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.32B | 0.83% | 179,931 | 253.83M |
| 148 | RDNT | RadNet, Inc. | 6.32B | 9.67% | 1,727,221 | 2.27B |
| 149 | HIMS | Hims & Hers Health, Inc. | 6.22B | 3.74% | 11,636,112 | 2.58B |
| 150 | BLTE | Belite Bio, Inc | 6.20B | 1.21% | 82,731 | - |
| 151 | DOCS | Doximity, Inc. | 6.18B | 6.35% | 3,000,584 | 655.57M |
| 152 | KOD | Kodiak Sciences Inc. | 6.18B | -0.38% | 1,004,008 | - |
| 153 | IMVT | Immunovant, Inc. | 6.18B | 2.96% | 1,270,484 | - |
| 154 | CGON | CG Oncology, Inc. | 6.00B | 5.70% | 1,393,920 | 6.23M |
| 155 | SUPN | Supernus Pharmaceuticals, Inc. | 5.86B | 0.21% | 6,565,162 | 1.37B |
| 156 | HAE | Haemonetics Corporation | 5.80B | 5.94% | 982,030 | 1.35B |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.76B | 1.25% | 1,343,631 | 1.16B |
| 158 | WAY | Waystar Holding Corp. | 5.71B | 7.34% | 3,258,440 | 1.26B |
| 159 | MANE | Veradermics, Incorporated | 5.70B | 2.17% | 562,500 | - |
| 160 | SRRK | Scholar Rock Holding Corporation | 5.61B | 4.80% | 1,710,476 | - |
| 161 | CON | Concentra Group Holdings Parent, Inc. | 5.55B | 8.49% | 2,669,329 | 2.29B |
| 162 | COGT | Cogent Biosciences, Inc. | 5.47B | 1.38% | 2,229,451 | - |
| 163 | LFST | LifeStance Health Group, Inc. | 5.43B | 6.28% | 4,056,295 | 1.68B |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.43B | 7.69% | 1,387,207 | 1.61B |
| 165 | MMED | MiniMed Group, Inc. | 5.43B | 2.33% | 11,782,704 | 3.22B |
| 166 | BLLN | BillionToOne, Inc. | 5.37B | 3.11% | 582,227 | 436.87M |
| 167 | ERAS | Erasca, Inc. | 5.21B | 1.84% | 3,501,513 | - |
| 168 | LIVN | LivaNova PLC | 5.19B | 17.88% | 3,788,920 | 1.51B |
| 169 | TVTX | Travere Therapeutics, Inc. | 5.03B | 6.09% | 3,668,731 | 651.03M |
| 170 | CRSP | CRISPR Therapeutics AG | 5.02B | 3.57% | 1,393,529 | 25.17M |
| 171 | HTFL | HeartFlow, Inc. | 4.92B | 3.99% | 1,592,498 | 212.07M |
| 172 | DNTH | Dianthus Therapeutics, Inc. | 4.80B | 3.76% | 1,679,419 | 2.72M |
| 173 | OPCH | Option Care Health, Inc. | 4.74B | -0.38% | 4,314,115 | 5.75B |
| 174 | SHC | Sotera Health Company | 4.68B | 2.25% | 4,614,773 | 1.23B |
| 175 | CDNA | CareDx, Inc. | 4.51B | -2.95% | 1,458,394 | 497.40M |
| 176 | IRTC | iRhythm Holdings, Inc. | 4.42B | 6.04% | 1,192,846 | 825.34M |
| 177 | LEGN | Legend Biotech Corporation | 4.41B | 6.01% | 3,155,972 | 1.27B |
| 178 | DFTX | Definium Therapeutics, Inc. | 4.39B | -2.13% | 1,413,598 | - |
| 179 | NVST | Envista Holdings Corporation | 4.37B | 9.77% | 6,113,934 | 2.88B |
| 180 | ICUI | ICU Medical, Inc. | 4.32B | 6.67% | 446,922 | 2.16B |
| 181 | ITGR | Integer Holdings Corporation | 4.31B | 0.07% | 730,232 | 1.83B |
| 182 | ARQT | Arcutis Biotherapeutics, Inc. | 4.28B | 6.41% | 2,747,440 | 508.68M |
| 183 | ADPT | Adaptive Biotechnologies Corporation | 4.26B | 3.53% | 2,328,998 | 298.01M |
| 184 | LQDA | Liquidia Corporation | 4.24B | 12.27% | 4,815,850 | 450.91M |
| 185 | VCYT | Veracyte, Inc. | 4.22B | 4.43% | 1,907,048 | 581.78M |
| 186 | EWTX | Edgewise Therapeutics, Inc. | 4.08B | -0.40% | 1,081,469 | - |
| 187 | PLSE | Pulse Biosciences, Inc. | 4.07B | 9.31% | 499,695 | 1.19M |
| 188 | ABCL | AbCellera Biologics Inc. | 3.98B | 0.82% | 2,671,257 | 66.17M |
| 189 | RLAY | Relay Therapeutics, Inc. | 3.95B | 3.38% | 3,729,958 | 10.35M |
| 190 | IOVA | Iovance Biotherapeutics, Inc. | 3.94B | -1.47% | 18,005,096 | 324.97M |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.91B | 0.04% | 2,464,316 | 53.81M |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.80B | 2.51% | 1,649,055 | 7.50M |
| 193 | PBLS | Parabilis Medicines, Inc. | 3.75B | 3.79% | 842,967 | 148.00K |
| 194 | ACAD | Acadia Pharmaceuticals Inc. | 3.70B | 4.38% | 4,719,961 | 1.20B |
| 195 | IRON | Disc Medicine, Inc. | 3.70B | 2.61% | 1,428,090 | - |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.69B | 0.68% | 1,586,283 | -665.00K |
| 197 | STVN | Stevanato Group S.p.A. | 3.67B | -4.68% | 4,406,656 | 1.42B |
| 198 | OGN | Organon & Co. | 3.63B | -0.14% | 2,648,046 | 6.10B |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.57B | 7.21% | 4,390,812 | - |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.46B | 2.71% | 3,649,306 | - |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.46B | 5.40% | 2,707,283 | - |
| 202 | TARS | Tarsus Pharmaceuticals, Inc. | 3.41B | -4.91% | 2,550,743 | 682.20M |
| 203 | CELC | Celcuity Inc. | 3.39B | -0.69% | 1,194,044 | - |
| 204 | DNLI | Denali Therapeutics Inc. | 3.36B | 7.76% | 4,900,063 | 21.38M |
| 205 | TLX | Telix Pharmaceuticals Limited | 3.35B | 7.09% | 531,932 | 890.79M |
| 206 | ATRC | AtriCure, Inc. | 3.33B | 8.48% | 1,335,733 | 589.80M |
| 207 | NHC | National HealthCare Corporation | 3.33B | 3.19% | 207,019 | 1.56B |
| 208 | VRDN | Viridian Therapeutics, Inc. | 3.29B | 15.53% | 11,177,585 | 26.31M |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 3.13B | 3.29% | 2,033,565 | 36.54M |
| 210 | BHC | Bausch Health Companies Inc. | 3.12B | 2.46% | 3,529,976 | 11.11B |
| 211 | AVAH | Aveanna Healthcare Holdings Inc. | 3.11B | 7.15% | 3,797,008 | 2.60B |
| 212 | AXGN | Axogen, Inc. | 3.07B | 3.74% | 1,865,979 | 266.93M |
| 213 | SGRY | Surgery Partners, Inc. | 3.00B | 0.13% | 11,092,274 | 3.37B |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 3.00B | 8.88% | 5,055,181 | 3.41B |
| 215 | PRVA | Privia Health Group, Inc. | 2.86B | 4.33% | 2,815,390 | 2.36B |
| 216 | ZLAB | Zai Lab Limited | 2.83B | 3.83% | 1,169,474 | 449.61M |
| 217 | RCUS | Arcus Biosciences, Inc. | 2.78B | 2.12% | 2,078,154 | 100.00M |
| 218 | BEAM | Beam Therapeutics Inc. | 2.77B | 5.55% | 1,348,236 | 146.64M |
| 219 | NEOG | Neogen Corporation | 2.72B | 2.98% | 4,511,770 | 884.00M |
| 220 | RGC | Regencell Bioscience Holdings Limited | 2.69B | -11.87% | 276,697 | - |
| 221 | BKD | Brookdale Senior Living Inc. | 2.67B | 7.91% | 5,735,837 | 2.93B |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.67B | 2.99% | 658,229 | 1.46B |
| 223 | WRBY | Warby Parker Inc. | 2.63B | -2.96% | 8,619,661 | 911.61M |
| 224 | XNCR | Xencor, Inc. | 2.60B | 14.33% | 2,539,436 | 200.49M |
| 225 | UFPT | UFP Technologies, Inc. | 2.55B | 17.66% | 358,641 | 649.52M |
| 226 | MBX | MBX Biosciences, Inc. | 2.53B | -4.58% | 424,993 | - |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.52B | 7.55% | 800,223 | 1.10B |
| 228 | TMDX | TransMedics Group, Inc. | 2.52B | 8.04% | 2,474,352 | 668.47M |
| 229 | NAMS | NewAmsterdam Pharma Company N.V. | 2.50B | 5.18% | 1,889,342 | 25.94M |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.50B | 7.19% | 1,185,405 | 1.96B |
| 231 | CLOV | Clover Health Investments, Corp. | 2.49B | 9.32% | 7,282,282 | 2.74B |
| 232 | RXRX | Recursion Pharmaceuticals, Inc. | 2.42B | 5.43% | 20,594,058 | 68.23M |
| 233 | HCM | HUTCHMED (China) Limited | 2.41B | 6.42% | 102,205 | 549.12M |
| 234 | PHVS | Pharvaris N.V. | 2.41B | -1.29% | 311,378 | - |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 0.74% | 911,486 | 158.00K |
| 236 | ADMA | ADMA Biologics, Inc. | 2.35B | -5.67% | 13,385,558 | 519.15M |
| 237 | ADUS | Addus HomeCare Corporation | 2.34B | 1.10% | 421,697 | 1.50B |
| 238 | PVLA | Palvella Therapeutics, Inc. | 2.34B | 6.11% | 407,144 | - |
| 239 | VCEL | Vericel Corporation | 2.33B | 10.68% | 1,807,628 | 306.30M |
| 240 | PGNY | Progyny, Inc. | 2.31B | 3.58% | 1,244,789 | 1.34B |
| 241 | VERA | Vera Therapeutics, Inc. | 2.30B | 4.10% | 1,985,326 | - |
| 242 | IMNM | Immunome, Inc. | 2.30B | -3.89% | 3,461,009 | 4.02M |
| 243 | BHVN | Biohaven Ltd. | 2.30B | -2.37% | 1,675,789 | - |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.29B | 3.32% | 1,477,029 | 321.74M |
| 245 | SEPN | Septerna, Inc. | 2.23B | 9.57% | 604,924 | 98.88M |
| 246 | TRLV | Trulieve Cannabis Corp. | 2.23B | 0.52% | 2,248,826 | 1.14B |
| 247 | NEO | NeoGenomics, Inc. | 2.22B | 1.90% | 1,149,926 | 787.75M |
| 248 | PRGO | Perrigo Company plc | 2.20B | 0.83% | 4,972,089 | 4.09B |
| 249 | ZYME | Zymeworks Inc. | 2.20B | 2.69% | 1,046,410 | 37.13M |
| 250 | LKFT | Lakefront Biotherapeutics NV | 2.14B | 6.03% | 447,220 | 1.13B |
| 251 | SDGR | Schrödinger, Inc. | 2.13B | 4.93% | 1,900,403 | 269.20M |
| 252 | XRAY | DENTSPLY SIRONA Inc. | 2.12B | 9.46% | 6,672,926 | 3.64B |
| 253 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.11B | -3.85% | 10,226,410 | 961.51M |
| 254 | COAG | Hemab Therapeutics Holdings, Inc. | 2.11B | 4.62% | 499,702 | - |
| 255 | WGS | GeneDx Holdings Corp. | 2.07B | 1.02% | 550,810 | 454.43M |
| 256 | TRAX | First Tracks Biotherapeutics, Inc. | 2.06B | 5.83% | 939,502 | - |
| 257 | ASTH | Astrana Health, Inc. | 2.03B | 8.00% | 460,965 | 3.84B |
| 258 | LMAT | LeMaitre Vascular, Inc. | 2.01B | 9.08% | 520,423 | 262.43M |
| 259 | FTRE | Fortrea Holdings Inc. | 2.01B | -0.57% | 1,435,009 | 2.67B |
| 260 | SRPT | Sarepta Therapeutics, Inc. | 2.01B | 2.43% | 1,482,485 | 1.97B |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.00B | 3.62% | 3,624,318 | 213.00M |
| 262 | HRMY | Harmony Biosciences Holdings, Inc. | 2.00B | -7.04% | 2,469,409 | 989.36M |
| 263 | ESTA | Establishment Labs Holdings Inc. | 1.99B | 9.02% | 386,801 | 264.03M |
| 264 | TRVI | Trevi Therapeutics, Inc. | 1.99B | 0.90% | 1,380,060 | - |
| 265 | VIR | Vir Biotechnology, Inc. | 1.99B | 4.90% | 2,804,943 | 302.80M |
| 266 | MESO | Mesoblast Limited | 1.97B | -3.25% | 357,406 | 120.25M |
| 267 | REPL | Replimune Group, Inc. | 1.96B | 0.19% | 3,215,127 | - |
| 268 | INSP | Inspire Medical Systems, Inc. | 1.93B | 7.61% | 862,095 | 880.94M |
| 269 | XERS | Xeris Biopharma Holdings, Inc. | 1.91B | 1.06% | 3,153,015 | 335.41M |
| 270 | ALMR | Alamar Biosciences, Inc. | 1.90B | -9.36% | 1,529,908 | 114.05M |
| 271 | AGIO | Agios Pharmaceuticals, Inc. | 1.87B | 0.58% | 1,106,273 | 98.34M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 1.85B | 0.28% | 800,741 | 1.00M |
| 273 | AMN | AMN Healthcare Services, Inc. | 1.85B | 5.39% | 610,931 | 3.43B |
| 274 | SLS | SELLAS Life Sciences Group, Inc. | 1.85B | 3.04% | 5,443,687 | - |
| 275 | ARDT | Ardent Health, Inc. | 1.83B | 10.93% | 1,077,533 | 6.45B |
| 276 | GENB | Generate Biomedicines, Inc. | 1.82B | 2.24% | 636,720 | 26.48M |
| 277 | KMTS | Kestra Medical Technologies, Ltd. | 1.82B | 5.14% | 1,893,544 | 106.73M |
| 278 | BFLY | Butterfly Network, Inc. | 1.81B | 5.78% | 5,891,048 | 123.26M |
| 279 | PGEN | Precigen, Inc. | 1.81B | -3.71% | 10,481,064 | 156.94M |
| 280 | MAZE | Maze Therapeutics, Inc. | 1.80B | 3.50% | 535,745 | 20.00M |
| 281 | ABSI | Absci Corporation | 1.80B | 4.80% | 4,157,965 | 1.56M |
| 282 | OMCL | Omnicell, Inc. | 1.80B | 11.14% | 850,498 | 1.24B |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.80B | 1.70% | 1,209,959 | 28.21M |
| 284 | HCSG | Healthcare Services Group, Inc. | 1.79B | 3.79% | 694,565 | 1.88B |
| 285 | TDOC | Teladoc Health, Inc. | 1.77B | 9.11% | 7,283,079 | 2.47B |
| 286 | NVAX | Novavax, Inc. | 1.76B | 10.02% | 6,032,170 | 413.80M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.75B | 8.73% | 675,009 | 481.07M |
| 288 | NRIX | Nurix Therapeutics, Inc. | 1.74B | -38.23% | 19,559,091 | 701.94M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 3.79% | 3,170,979 | 59.51M |
| 290 | AZTA | Azenta, Inc. | 1.71B | 5.39% | 916,364 | 613.81M |
| 291 | NVCR | NovoCure Limited | 1.71B | 8.79% | 1,647,845 | 725.39M |
| 292 | ALHC | Alignment Healthcare, Inc. | 1.70B | 10.15% | 5,565,610 | 4.94B |
| 293 | CERT | Certara, Inc. | 1.69B | 2.02% | 2,425,078 | 421.75M |
| 294 | RARE | Ultragenyx Pharmaceutical Inc. | 1.69B | 3.19% | 7,509,307 | 730.00M |
| 295 | PSNL | Personalis, Inc. | 1.69B | 0.25% | 2,217,754 | 80.77M |
| 296 | ADRX | ADARx Pharmaceuticals, Inc. | 1.68B | -7.02% | 377,837 | 6.13M |
| 297 | LYCA | Lycia Therapeutics, Inc. | 1.67B | 4.78% | 302,655 | 4.44M |
| 298 | ALVO | Alvotech | 1.67B | 2.86% | 668,971 | 494.61M |
| 299 | NUVB | Nuvation Bio Inc. | 1.66B | 0.85% | 8,411,925 | 201.73M |
| 300 | KLRA | Kailera Therapeutics, Inc. | 1.66B | 1.75% | 651,268 | - |
| 301 | BRVE | Braveheart Bio, Inc. | 1.64B | -6.01% | 655,545 | - |
| 302 | AGL | agilon health, inc. | 1.62B | 9.61% | 283,117 | 6.00B |
| 303 | PAHC | Phibro Animal Health Corporation | 1.60B | 4.73% | 266,662 | 1.54B |
| 304 | CNMD | CONMED Corporation | 1.60B | 13.61% | 592,355 | 1.37B |
| 305 | QURE | uniQure N.V. | 1.60B | -3.52% | 2,664,113 | 20.17M |
| 306 | OCUL | Ocular Therapeutix, Inc. | 1.57B | 4.69% | 3,360,665 | 52.06M |
| 307 | PNTG | The Pennant Group, Inc. | 1.54B | 6.92% | 370,005 | 1.17B |
| 308 | INVA | Innoviva, Inc. | 1.54B | 1.58% | 922,346 | 438.32M |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -0.87% | 304,431 | 978.38M |
| 310 | RAPP | Rapport Therapeutics, Inc. | 1.53B | 1.93% | 956,868 | 20.00M |
| 311 | NBTX | Nanobiotix S.A. | 1.53B | 3.99% | 229,537 | 13.15M |
| 312 | IMCR | Immunocore Holdings plc | 1.51B | -2.66% | 685,797 | 430.78M |
| 313 | MLYS | Mineralys Therapeutics, Inc. | 1.50B | 6.32% | 1,925,339 | - |
| 314 | TYRA | Tyra Biosciences, Inc. | 1.48B | 0.73% | 542,627 | - |
| 315 | KARD | Kardigan, Inc. | 1.45B | 8.66% | 491,054 | - |
| 316 | GPCR | Structure Therapeutics Inc. | 1.45B | 0.05% | 738,527 | - |
| 317 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 2,420,575 | 746.16M |
| 318 | ETON | Eton Pharmaceuticals, Inc. | 1.45B | -0.45% | 375,316 | 105.60M |
| 319 | TSHA | Taysha Gene Therapies, Inc. | 1.42B | 6.60% | 4,033,565 | 5.49M |
| 320 | ANAB | AnaptysBio, Inc. | 1.42B | -0.46% | 528,258 | 106.09M |
| 321 | AAPG | Ascentage Pharma Group International | 1.42B | 11.80% | 19,654 | 94.61M |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.42B | 3.89% | 736,740 | - |
| 323 | ENOV | Enovis Corporation | 1.41B | 16.90% | 3,805,488 | 2.31B |
| 324 | NUTX | Nutex Health Inc. | 1.41B | 14.28% | 164,964 | 846.72M |
| 325 | URGN | UroGen Pharma Ltd. | 1.40B | -16.45% | 2,897,471 | 250.25M |
| 326 | KRSA | Korsana Biosciences, Inc. | 1.39B | -4.38% | 122,700 | - |
| 327 | GHRS | GH Research PLC | 1.37B | -1.73% | 298,890 | - |
| 328 | STAA | STAAR Surgical Company | 1.36B | 7.95% | 984,879 | 328.27M |
| 329 | INNV | InnovAge Holding Corp. | 1.34B | 10.62% | 1,078,816 | 1.02B |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.33B | 5.24% | 283,263 | 829.86M |
| 331 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 7.93% | 3,714,651 | 1.04B |
| 332 | OPK | OPKO Health, Inc. | 1.32B | 2.91% | 4,834,429 | 654.10M |
| 333 | LBRX | LB Pharmaceuticals Inc | 1.32B | 1.29% | 365,764 | - |
| 334 | OMER | Omeros Corporation | 1.32B | -0.49% | 976,424 | 38.42M |
| 335 | NKTR | Nektar Therapeutics | 1.31B | 1.91% | 498,473 | 54.59M |
| 336 | CRON | Cronos Group Inc. | 1.30B | 3.85% | 2,118,772 | 179.09M |
| 337 | DRTS | Alpha Tau Medical Ltd. | 1.30B | 3.62% | 688,492 | - |
| 338 | AORT | Artivion, Inc. | 1.29B | 11.56% | 1,086,570 | 471.47M |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.28B | 10.84% | 7,144,402 | 839.72M |
| 340 | INBX | Inhibrx Biosciences, Inc. | 1.28B | 7.01% | 190,215 | 1.30M |
| 341 | GDRX | GoodRx Holdings, Inc. | 1.27B | 6.59% | 2,132,190 | 785.23M |
| 342 | MNKD | MannKind Corporation | 1.26B | 5.36% | 4,060,116 | 393.63M |
| 343 | LMRI | Lumexa Imaging Holdings, Inc. | 1.26B | 16.76% | 1,332,248 | 1.04B |
| 344 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | 7.39% | 2,847,937 | 352.31M |
| 345 | VOR | Vor Biopharma Inc. | 1.24B | 1.31% | 415,418 | - |
| 346 | AVLN | Avalyn Pharma Inc. | 1.22B | 2.46% | 455,276 | - |
| 347 | FRNM | Freenome, Inc. | 1.21B | -1.48% | 757,730 | 35.41M |
| 348 | VSTM | Verastem, Inc. | 1.20B | 0.82% | 2,514,257 | 87.53M |
| 349 | SLN | Silence Therapeutics plc | 1.19B | 0.10% | 1,023,284 | 615.00K |
| 350 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.19B | 3.32% | 644,914 | 730.02M |
| 351 | CMPS | COMPASS Pathways plc | 1.19B | 0.12% | 5,256,100 | - |
| 352 | OMDA | Omada Health, Inc. | 1.19B | 4.57% | 707,300 | 309.76M |
| 353 | SVRA | Savara Inc. | 1.18B | -1.89% | 3,560,043 | - |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.15B | 8.73% | 1,174,234 | 1.66B |
| 355 | SGP | SpyGlass Pharma, Inc. | 1.15B | - | 201,019 | - |
| 356 | AHG | Akso Health Group | 1.14B | 9.92% | 9,004 | 13.83M |
| 357 | IRMD | IRADIMED CORPORATION | 1.13B | 9.21% | 184,057 | 89.34M |
| 358 | SIBN | SI-BONE, Inc. | 1.13B | 4.96% | 2,186,973 | 220.65M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 3.76% | 336,175 | - |
| 360 | JANX | Janux Therapeutics, Inc. | 1.11B | 2.02% | 976,178 | 24.00M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.09B | 1.74% | 462,477 | 357.28M |
| 362 | HROW | Harrow, Inc. | 1.08B | 0.74% | 778,033 | 275.59M |
| 363 | CBLL | CeriBell, Inc. | 1.06B | -3.11% | 1,271,937 | 108.72M |
| 364 | HSTM | HealthStream, Inc. | 993.75M | 2.56% | 310,502 | 327.95M |
| 365 | QDEL | QuidelOrtho Corporation | 984.06M | 1.85% | 3,283,599 | 2.59B |
| 366 | MLTX | MoonLake Immunotherapeutics | 983.83M | -1.20% | 1,226,081 | - |
| 367 | AHCO | AdaptHealth Corp. | 976.55M | 16.40% | 6,328,426 | 3.44B |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 968.12M | -2.61% | 2,958,659 | - |
| 369 | GMRS | GMR Solutions Inc. | 962.97M | 8.78% | 1,246,152 | 5.88B |
| 370 | BVS | Bioventus Inc. | 962.26M | 4.29% | 1,264,935 | 585.64M |
| 371 | RIGL | Rigel Pharmaceuticals, Inc. | 958.09M | 4.97% | 288,613 | 276.79M |
| 372 | JBIO | Jade Biosciences, Inc. | 956.50M | 3.23% | 1,136,186 | - |
| 373 | IMTX | Immatics N.V. | 944.53M | -2.40% | 678,244 | 47.65M |
| 374 | SNDX | Syndax Pharmaceuticals, Inc. | 940.80M | -26.87% | 15,060,843 | 289.68M |
| 375 | IVA | Inventiva S.A. | 939.98M | -3.97% | 1,578,939 | 2.81M |
| 376 | ODTX | Odyssey Therapeutics, Inc. | 934.41M | -9.60% | 675,499 | 99.00K |
| 377 | LTGO | Latigo Biotherapeutics, Inc. | 930.84M | -3.64% | 155,965 | - |
| 378 | GLUE | Monte Rosa Therapeutics, Inc. | 923.09M | 3.94% | 1,962,064 | 28.73M |
| 379 | BBNX | Beta Bionics, Inc. | 921.52M | 12.25% | 1,178,984 | 127.27M |
| 380 | ANRO | Alto Neuroscience, Inc. | 914.34M | 2.64% | 449,161 | - |
| 381 | MGTX | MeiraGTx Holdings plc | 904.73M | -1.05% | 597,710 | 397.50M |
| 382 | CRVS | Corvus Pharmaceuticals, Inc. | 889.16M | 7.53% | 1,959,126 | - |
| 383 | PRME | Prime Medicine, Inc. | 884.18M | 9.23% | 4,397,788 | 4.07M |
| 384 | PHAR | Pharming Group N.V. | 880.46M | -3.63% | 26,883 | 386.75M |
| 385 | KIDS | OrthoPediatrics Corp. | 874.96M | 6.69% | 555,390 | 264.14M |
| 386 | ALMS | Alumis Inc. | 847.80M | 0.77% | 1,290,062 | 7.40M |
| 387 | AKTS | Aktis Oncology, Inc. | 845.42M | 1.74% | 243,234 | 10.06M |
| 388 | ARDX | Ardelyx, Inc. | 827.02M | 8.58% | 10,874,645 | 468.22M |
| 389 | ANNX | Annexon, Inc. | 820.88M | 3.34% | 4,450,623 | - |
| 390 | BBTX | Bambusa Therapeutics, Inc. | 818.64M | 0.44% | 251,937 | - |
| 391 | PHR | Phreesia, Inc. | 818.10M | 7.77% | 616,638 | 507.79M |
| 392 | CTY | City Therapeutics, Inc. | 816.51M | -14.04% | 359,825 | 14.34M |
| 393 | INMD | InMode Ltd. | 816.23M | 0.85% | 807,200 | 374.63M |
| 394 | CGEM | Cullinan Therapeutics, Inc. | 803.79M | -20.70% | 2,203,294 | - |
| 395 | ABUS | Arbutus Biopharma Corporation | 803.26M | 4.64% | 2,778,864 | 181.72M |
| 396 | PACB | Pacific Biosciences of California, Inc. | 792.62M | 4.51% | 20,974,349 | 161.39M |
| 397 | DNA | Ginkgo Bioworks Holdings, Inc. | 784.51M | 8.27% | 2,691,670 | 132.42M |
| 398 | VREX | Varex Imaging Corporation | 780.16M | -0.11% | 647,138 | 865.00M |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 770.59M | -0.25% | 803,991 | 808.21M |
| 400 | SANA | Sana Biotechnology, Inc. | 766.36M | 4.92% | 2,642,904 | - |
| 401 | CTKB | Cytek Biosciences, Inc. | 764.30M | -1.34% | 1,567,839 | 207.65M |
| 402 | OABI | OmniAb, Inc. | 755.56M | 0.58% | 1,142,446 | 40.21M |
| 403 | ACHV | Achieve Life Sciences, Inc. | 718.26M | 3.71% | 1,393,745 | - |
| 404 | WVE | Wave Life Sciences, Inc. | 713.97M | 1.12% | 2,745,458 | 70.92M |
| 405 | ATTO | Attovia Therapeutics, Inc. | 712.16M | 2.16% | 327,679 | 1.80M |
| 406 | SGMT | Sagimet Biosciences Inc. | 708.38M | 0.40% | 756,445 | - |
| 407 | STLN | Starling Oncology, Inc. | 707.30M | 9.46% | 1,688,231 | 587.24M |
| 408 | SLDB | Solid Biosciences Inc. | 699.11M | 3.82% | 1,058,636 | - |
| 409 | GERN | Geron Corporation | 693.87M | 16.13% | 26,877,526 | 217.52M |
| 410 | CADL | Candel Therapeutics, Inc. | 692.49M | 2.61% | 993,819 | - |
| 411 | AURA | Aura Biosciences, Inc. | 689.64M | 6.57% | 1,001,929 | - |
| 412 | OBX | Obsidian Therapeutics, Inc. | 678.88M | -16.93% | 544,019 | - |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 678.40M | 2.76% | 764,668 | 92.01M |
| 414 | KURA | Kura Oncology, Inc. | 676.99M | -22.98% | 8,213,402 | 77.23M |
| 415 | DSGN | Design Therapeutics, Inc. | 665.24M | 2.80% | 314,980 | - |
| 416 | AVBP | ArriVent BioPharma, Inc. | 665.16M | 3.61% | 1,859,288 | - |
| 417 | ZVRA | Zevra Therapeutics, Inc. | 664.67M | 8.87% | 2,064,685 | 147.76M |
| 418 | IMMX | Immix Biopharma, Inc. | 660.74M | 3.37% | 1,249,717 | - |
| 419 | OLMA | Olema Pharmaceuticals, Inc. | 659.73M | 2.59% | 1,091,023 | - |
| 420 | LXRX | Lexicon Pharmaceuticals, Inc. | 658.53M | 1.37% | 1,949,861 | 41.47M |
| 421 | APMD | Apnimed, Inc. | 636.95M | 1.59% | 604,510 | 115.12M |
| 422 | IAM | Iambic Therapeutics, Inc. | 635.17M | -0.67% | 293,881 | 18.25M |
| 423 | HELP | Helus Pharma Inc. | 634.16M | -3.88% | 1,253,269 | - |
| 424 | SLBT | SL Science Holding Limited | 633.00M | -9.02% | 40,084 | 3.27M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 622.95M | 7.71% | 2,571,635 | 389.32M |
| 426 | DBVT | DBV Technologies S.A. | 621.99M | -1.68% | 378,307 | 3.74M |
| 427 | ANL | Adlai Nortye Group Ltd. | 618.86M | 0.31% | 238,623 | 18.06M |
| 428 | TCMD | Tactile Systems Technology, Inc. | 608.87M | 9.69% | 861,545 | 356.42M |
| 429 | NVCT | Nuvectis Pharma, Inc. | 601.78M | -4.50% | 373,435 | - |
| 430 | AVR | Anteris Technologies Global Corp. | 596.66M | 9.29% | 1,156,907 | 2.24M |
| 431 | SOPH | SOPHiA GENETICS SA | 593.34M | 0.87% | 1,343,621 | 90.97M |
| 432 | CBIO | Crescent Biopharma, Inc. | 591.51M | 5.82% | 172,846 | 11.88M |
| 433 | BCAX | Bicara Therapeutics Inc. | 588.28M | -0.78% | 1,052,115 | - |
| 434 | DMAC | DiaMedica Therapeutics Inc. | 580.78M | 7.70% | 409,096 | - |
| 435 | MYGN | Myriad Genetics, Inc. | 575.81M | -0.33% | 2,112,705 | 803.60M |
| 436 | EVO | Evotec SE | 575.68M | 1.29% | 55,725 | 815.72M |
| 437 | NRC | NRC Health | 574.47M | 12.46% | 247,480 | 143.79M |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 570.34M | -1.60% | 2,045,279 | 8.22M |
| 439 | SRZN | Surrozen, Inc. | 553.72M | 5.08% | 231,057 | 11.51M |
| 440 | NGNE | Neurogene Inc. | 551.91M | 3.41% | 208,920 | 925.00K |
| 441 | PBYI | Puma Biotechnology, Inc. | 551.82M | 4.60% | 475,209 | 231.24M |
| 442 | EVH | Evolent Health, Inc. | 542.68M | 11.63% | 2,602,156 | 2.10B |
| 443 | FLGT | Fulgent Genetics, Inc. | 541.50M | 1.60% | 363,967 | 323.93M |
| 444 | ENTX | Entera Bio Ltd. | 540.90M | 1.97% | 291,240 | 42.00K |
| 445 | VALN | Valneva SE | 538.87M | 2.18% | 6,670 | 163.30M |
| 446 | CLYM | Climb Bio, Inc. | 535.88M | -4.31% | 1,044,048 | - |
| 447 | OVID | Ovid Therapeutics Inc. | 535.12M | 14.17% | 3,610,175 | 1.58M |
| 448 | SGHT | Sight Sciences, Inc. | 533.25M | 2.76% | 629,734 | 88.40M |
| 449 | CAPR | Capricor Therapeutics, Inc. | 518.60M | 8.25% | 6,439,133 | 11.13M |
| 450 | STTK | Shattuck Labs, Inc. | 516.87M | -5.85% | 870,604 | 1.00M |
| 451 | FTH | Faeth Therapeutics, Inc. | 516.55M | 1.73% | 237,138 | - |
| 452 | ANGO | AngioDynamics, Inc. | 515.17M | 4.43% | 868,829 | 325.38M |
| 453 | DCTH | Delcath Systems, Inc. | 514.24M | 2.92% | 394,794 | 95.42M |
| 454 | CTMX | CytomX Therapeutics, Inc. | 512.06M | 7.80% | 6,592,561 | 18.30M |
| 455 | RGNX | REGENXBIO Inc. | 508.96M | 1.05% | 1,310,372 | 174.48M |
| 456 | INDP | Indaptus Therapeutics, Inc. | 506.82M | 1.85% | 111,354 | - |
| 457 | RCEL | AVITA Medical, Inc. | 504.73M | 6.46% | 537,493 | 75.63M |
| 458 | MCTA | Charming Medical Limited | 504.26M | -0.02% | 4,251,392 | 4.81M |
| 459 | ETRA | Electra Therapeutics, Inc. | 500.25M | -1.24% | 437,031 | - |
| 460 | EOLS | Evolus, Inc. | 493.40M | 1.36% | 849,823 | 325.47M |
| 461 | YDES | YD Bio Limited | 492.28M | 8.59% | 81,402 | 1.24M |
| 462 | MNPR | Monopar Therapeutics Inc. | 488.71M | 4.18% | 189,611 | - |
| 463 | CERS | Cerus Corporation | 487.72M | 3.21% | 2,512,557 | 226.57M |
| 464 | ARVN | Arvinas, Inc. | 485.90M | 4.65% | 1,233,067 | 275.30M |
| 465 | AQST | Aquestive Therapeutics, Inc. | 477.61M | -2.06% | 3,315,368 | 48.84M |
| 466 | SENS | Senseonics Holdings, Inc. | 476.92M | 1.81% | 739,876 | 48.55M |
| 467 | GYRE | Gyre Therapeutics, Inc. | 470.79M | - | 256,453 | 109.82M |
| 468 | MDXG | MiMedx Group, Inc. | 466.96M | -1.54% | 1,837,701 | 303.73M |
| 469 | SRTA | Strata Critical Medical, Inc. | 466.25M | 17.57% | 2,572,658 | 280.76M |
| 470 | NPCE | NeuroPace, Inc. | 457.89M | 8.37% | 227,882 | 106.99M |
| 471 | MASS | 908 Devices Inc. | 457.56M | 3.75% | 312,803 | 60.84M |
| 472 | SSII | SS Innovations International, Inc. | 454.87M | -2.58% | 31,883 | 52.40M |
| 473 | TKNO | Alpha Teknova, Inc. | 454.75M | 0.41% | 372,105 | 45.95M |
| 474 | PHAT | Phathom Pharmaceuticals, Inc. | 451.16M | -1.05% | 1,514,099 | 274.88M |
| 475 | BWAY | BrainsWay Ltd. | 449.56M | 0.54% | 92,271 | 60.70M |
| 476 | OCS | Oculis Holding AG | 449.41M | -4.59% | 550,216 | 1.12M |
| 477 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.53M | -1.74% | 660,269 | - |
| 478 | RLMD | Relmada Therapeutics, Inc. | 444.81M | -2.34% | 2,635,238 | - |
| 479 | CRMD | CorMedix Inc. | 441.16M | 1.80% | 1,492,242 | 462.25M |
| 480 | CARL | Carlsmed, Inc. | 439.30M | 11.74% | 90,829 | 63.30M |
| 481 | SI | Shoulder Innovations, Inc. | 437.41M | 6.00% | 104,189 | 60.06M |
| 482 | TLRY | Tilray Brands, Inc. | 434.12M | 11.70% | 12,713,850 | 963.10M |
| 483 | PRTA | Prothena Corporation plc | 430.72M | 2.19% | 289,192 | 54.53M |
| 484 | PRLD | Prelude Therapeutics Incorporated | 420.22M | 7.94% | 378,923 | 22.42M |
| 485 | EDIT | Editas Medicine, Inc. | 417.74M | 4.62% | 2,368,804 | 47.01M |
| 486 | RZLT | Rezolute, Inc. | 415.39M | -1.25% | 1,074,155 | - |
| 487 | ALT | Altimmune, Inc. | 412.38M | 3.92% | 3,484,110 | 31.00K |
| 488 | ALLO | Allogene Therapeutics, Inc. | 411.13M | 6.25% | 16,530,287 | 4.64M |
| 489 | KMDA | Kamada Ltd. | 407.97M | 2.34% | 109,583 | 191.85M |
| 490 | ASMB | Assembly Biosciences, Inc. | 404.57M | -0.25% | 269,005 | 74.85M |
| 491 | TECX | Tectonic Therapeutic, Inc. | 396.85M | 6.95% | 221,545 | - |
| 492 | OFIX | Orthofix Medical Inc. | 395.92M | 10.96% | 1,170,810 | 833.19M |
| 493 | BLSM | BlossomHill Therapeutics, Inc. | 393.50M | -0.24% | 297,402 | - |
| 494 | ZURA | Zura Bio Limited | 387.23M | 0.75% | 1,947,882 | - |
| 495 | VMD | Viemed Healthcare, Inc. | 385.07M | 6.87% | 235,161 | 310.37M |
| 496 | CTNM | Contineum Therapeutics, Inc. | 384.41M | 1.03% | 804,448 | - |
| 497 | CCCC | C4 Therapeutics, Inc. | 383.84M | -2.80% | 1,972,433 | 35.04M |
| 498 | AVTX | Avalo Therapeutics, Inc. | 379.16M | -2.48% | 1,378,595 | 59.00K |
| 499 | LYEL | Lyell Immunopharma, Inc. | 378.11M | 43.27% | 1,101,235 | 15.00K |
| 500 | MOBI | Mobia Medical, Inc. | 374.19M | 12.74% | 380,254 | 45.28M |